The DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) 1 trial proved that insulin-glucose infusion followed by intensive subcutaneous insulin in 620 diabetic AMI patients improved 1- and 3.4-year survival [44]. Here, INS is linked to myocardial infarction.